Imatinib intermediate is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to signal to each other to grow. They act as chemical messengers. There are a number of different tyrosine kinases and blocking them stops the cancer cells growing.

152460-10-1:

Imatinib intermediate

Specifications:

Intermediate CAS No’s API/End Use Status Purity
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine 152460-10-1 Imatinib Commercial NLT 99%
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride 106261-49-8 Imatinib Commercial NLT 99%
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine 152460-09-8 Imatinib Commercial